Comprehensive analysis of the pharmaceutical market of oral hypoglycemic drugs in the Luhansk People’s Republic

Aim – to study the local pharmaceutical market of the Luhansk People’s Republic, compare it with the Russian and international market and determine the characteristic features of the market. Material and methods. The data of the pharmacy chains of the republic, information and reference materials on oral hypoglycemic drugs registered in the world and in the territory of the Russian Federation were used as research objects. To achieve this goal, graphical, comparative, structural and marketing methods were used. Results. The global market of oral hypoglycemic drugs is represented by 10 subgroups, 90 international nonproprietary names (INN) and their combinations. There are 35 INNs and 457 trade names (TN) registered on the Russian market. The pharmaceutical market of the republic is represented by 17 INNs and 71 TNs of medicines of the studied group. The share of domestic and foreign drugs on the market is 73.24% and 26.76%, respectively. Among all foreign drugs, 31.58% are produced in Germany, 15.79% each in India, Slovenia and Romania, 10.53% in France, 5.26% each in Greece and the USA. The breadth coefficient is 0.75; the depth coefficient in the republic is 0.55; the range completeness coefficient is 0.15. The average cost of monthly therapy with oral hypoglycemic drugs is calculated in the amount of 679.98 rubles. The capacity of the pharmaceutical market remained stable; the coefficient of variation in the period from 2018 to 2023 was 14.46%. Conclusion. The comparison of the pharmaceutical market of the republic with the world and Russian is carried out, the coefficients of breadth, depth and completeness of the assortment are calculated. Using the method of established daily doses, the average monthly cost of therapy was calculated and the potential capacity of the oral hypoglycemic drugs market from 2018 to 2023 was calculated and illustrated.